यूरोपीय संघ -
जर्मन -
EMA (European Medicines Agency)
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische mittel - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
यूरोपीय संघ -
जर्मन -
EMA (European Medicines Agency)
numient
amneal pharma europe ltd - levodopa, carbidopa - parkinson krankheit - anti-parkinson-medikamente - symptomatische behandlung von erwachsenen patienten mit parkinson-krankheit.
स्विट्ज़रलैंड -
जर्मन -
Swissmedic (Swiss Agency for Therapeutic Products)
plegridy 63 mcg/0,5 ml
biogen switzerland ag - peginterferonum beta-1a - 63 mcg/0,5 ml - peginterferonum beta-1a 63 µg l-arginini hydrochloridum, natrii acetas trihydricus, säure aceticum glaciale, polysorbatum 20, wasser iniectabilia q.s. zu einer lösung anstelle von 0,5 ml. - multiple sklerose - biotechnologika
स्विट्ज़रलैंड -
जर्मन -
Swissmedic (Swiss Agency for Therapeutic Products)
plegridy 94 mcg/0,5 ml
biogen switzerland ag - peginterferonum beta-1a - 94 mcg/0,5 ml - peginterferonum beta-1a 94 µg l-arginini hydrochloridum, natrii acetas trihydricus, säure aceticum glaciale, polysorbatum 20, wasser iniectabilia q.s. zu einer lösung anstelle von 0,5 ml. - multiple sklerose - biotechnologika
स्विट्ज़रलैंड -
जर्मन -
Swissmedic (Swiss Agency for Therapeutic Products)
plegridy 125 mcg/0,5 ml
biogen switzerland ag - peginterferonum beta-1a - 125 mcg/0,5 ml - peginterferonum beta-1a 125 µg, l-arginini hydrochloridum, natrii acetas trihydricus, säure aceticum glaciale, polysorbatum 20, wasser iniectabilia q.s. zu einer lösung anstelle von 0,5 ml. - multiple sklerose - biotechnologika
स्विट्ज़रलैंड -
जर्मन -
Swissmedic (Swiss Agency for Therapeutic Products)
plegridy pen 63 mcg/0,5 ml
biogen switzerland ag - peginterferonum beta-1a - 63 mcg/0,5 ml - peginterferonum beta-1a 63 µg, arginini hydrochloridum, natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika
स्विट्ज़रलैंड -
जर्मन -
Swissmedic (Swiss Agency for Therapeutic Products)
plegridy pen 94 mcg/0,5 ml
biogen switzerland ag - peginterferonum beta-1a - 94 mcg/0,5 ml - peginterferonum beta-1a 94 µg, arginini hydrochloridum, natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika
स्विट्ज़रलैंड -
जर्मन -
Swissmedic (Swiss Agency for Therapeutic Products)
plegridy pen 125 mcg/0,5 ml
biogen switzerland ag - peginterferonum beta-1a - 125 mcg/0,5 ml - peginterferonum beta-1a 125 µg, arginini hydrochloridum, natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika
जर्मनी -
जर्मन -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
apixaban intas 2,5 mg filmtabletten
intas third party sales 2005 s.l. (8184005) - apixaban - filmtablette - 2,5 mg - teil 1 - filmtablette; apixaban (34778) 2,5 milligramm
जर्मनी -
जर्मन -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
apixaban-ratiopharm 2,5 mg filmtabletten
ratiopharm gmbh (3087881) - apixaban - filmtablette - 2,5 mg - teil 1 - filmtablette; apixaban (34778) 2,5 milligramm